From: Comparison of metastasis between early-onset and late-onset gastric signet ring cell carcinoma
Variables | Total | Early-onset GSRCC | Late-onset GSRCC | P value |
---|---|---|---|---|
Total | 70 | 35 | 35 | |
Sex | 1 | |||
Male | 40 (57.14%) | 20 (57.14%) | 20 (57.14%) | |
Female | 30 (42.86%) | 15 (42.86%) | 15 (42.86%) | |
Smoke | 0.255 | |||
Never | 54 (77.14%) | 29 (82.86%) | 25 (71.43%) | |
Yes | 16 (22.86%) | 6 (17.14%) | 10 (28.57%) | |
Primary site | 0.4 | |||
Cardia | 3 (4.29%) | 1 (2.85%) | 2 (5.71%) | |
Fundus | 3 (4.29%) | 1 (2.85%) | 2 (5.71%) | |
Antrum | 42 (60%) | 19 (54.28%) | 23 (65.71%) | |
Body | 20 (28.57%) | 13 (37.14%) | 7 (20%) | |
Overlappping/NOS | 2 (2.86%) | 1 (2.85%) | 1 (2.85%) | |
T stage | 0.576 | |||
T1 | 8 (11.43%) | 4 (11.43%) | 4 (11.43%) | |
T2 | 10 (14.28%) | 5 (14.29%) | 5 (14.29%) | |
T3 | 10 (14.28%) | 7 (20%) | 3 (8.57%) | |
T4 | 42 (60%) | 19 (54.28%) | 23 (65.71%) | |
N stage | 0.63 | |||
N0 | 139 (34.49%) | 9 (25.71%) | 8 (22.86%) | |
N1 | 60 (14.89%) | 2 (5.71%) | 5 (14.29%) | |
N2 | 19 (27.14%) | 9 (25.71%) | 10 (28.57%) | |
N3 | 27 (72.86%) | 15 (42.86%) | 12 (34.29%) | |
M stage | 0.045 | |||
M0 | 59 (84.29%) | 26 (74.29%) | 33 (94.29%) | |
M1 | 11 (15.71%) | 9 (25.71%) | 2 (5.71%) | |
Lesion classification | 0.689 | |||
Infiltration type | 6 (8.57%) | 4 (11.43%) | 2 (5.71%) | |
Ulcerative type | 52 (74.29%) | 25 (71.43%) | 27 (77.14%) | |
Protuberant type | 12 (17.14%) | 6 (17.14%) | 6 (17.14%) | |
Lymphatic vessel invasion | 0.621 | |||
No | 26 (37.14%) | 12 (34.29%) | 14 (40%) | |
Yes | 44 (62.86%) | 23 (65.71%) | 21(60%) | |
Tumor size | 0.203 | |||
≤ 2 cm | 22 (31.43%) | 8 (22.86%) | 14 (40%) | |
≤ 5 cm | 33 (47.14%) | 20 (57.14%) | 13 (37.14%) | |
> 5 cm | 15 (21.43%) | 7 (20%) | 8 (22.86%) | |
Examined LNs | 0.495 | |||
≤ 16 | 10 (14.29%) | 6 (17.14%) | 4 (11.43%) | |
> 16 | 60 (85.71%) | 29 (82.86%) | 31 (88.57%) | |
Chemotherapy | 1 | |||
No | 38 (54.29%) | 19 (54.29%) | 19 (54.29%) | |
Yes | 32 (45.71%) | 16 (45.71%) | 16 (45.71%) |